COMMUNIQUÉS West-GlobeNewswire

Dynavax Reports Data for Phase 1b/2 Trial of SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Advanced Melanoma at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
04/06/2018
Overall Response Rate (ORR) of 70% and 6-month Progression Free Survival (PFS) rate of 76% in Patients Naïve to Anti-PD-1 Treatment who Received the ≤ 2mg Dose of SD -101 Combination showed Similar Rates of Immune- [...]
RadNet, Inc. to Present at the Jefferies 2018 Healthcare Conference on June 7, 2018
04/06/2018
LOS ANGELES, June 04, 2018 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient [...]
Ossur Hf : Transactions in relation to share buyback program
04/06/2018
Announcement no. 38/2018 Reykjavik, 4 June 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
Sensorion’s Chair of Scientific Advisory Board, Prof. Christine Petit, Awarded 2018 Kavli Prize in Neuroscience
04/06/2018
Christine Petit, A. James Hudspeth, and Robert Fettiplace recognized for their pioneering work on the molecular and neural mechanisms of hearing. MONTPELLIER, France, June 04, 2018 (GLOBE NEWSWIRE) -- Sensorion ( [...]
Veloxis Partners with the American Society of Transplant Surgeons to Award First Annual ASTS-Veloxis Fellowship in Transplantation
04/06/2018
Investor News no. 02/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 04 June 2018 Veloxis Partners with the American Society of Transplant Surgeons to Award First Annual ASTS-Veloxis Fellowship in Transplantation [...]
Helsinn: Second Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, supported by Helsinn, awarded to Rajiv Agarwal, MD, Memorial Sloan Kettering Cancer Center
04/06/2018
Second Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, supported by Helsinn, awarded to Rajiv Agarwal, MD, Memorial Sloan Kettering Cancer Center Lugano, [...]
Shire plc : Director/PDMR Shareholding
04/06/2018
Director/PDMR Shareholding June 4, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") Notification of transactions by person discharging managerial responsibilities 1. Details of the person discharging managerial [...]
Ernst & Young LLP (EY) Announces Nelipak CEO Mike Kelly as Entrepreneur of the Year® 2018 Award Finalist for New England Region
04/06/2018
BOSTON, June 04, 2018 (GLOBE NEWSWIRE) -- EY today announced that Mike Kelly, president and CEO of Nelipak ® Healthcare Packaging (“Nelipak”), a full-service global provider of custom thermoformed packaging that [...]
VAYA™ Pharma Launches Vayarin® Plus Medical Food for the Management of ADHD in Adults and Adolescents
04/06/2018
New Non-Drug Medical Food Clinically Shown to Improve ADHD Behaviors in Adults COLUMBIA, MD., June 04, 2018 (GLOBE NEWSWIRE) -- VAYA™ Pharma, Inc. (VAYA™), a division of Frutarom, Industries Ltd. (LSE:FRUT) (TASE:FRUT) [...]
Mersana Presents Interim Dose-Escalation Data on XMT-1522 in Select Cancers at ASCO 2018
04/06/2018
Favorable Tolerability Profile and Early Signs of Efficacy Demonstrated First Disclosure of Clinical Data from Novel Dolaflexin Platform Mersana To Host Conference Call and Webcast Including Principal Investigator, [...]
TG Therapeutics, Inc. Announces Umbralisib Clinical Data Presentation at the 54th Annual Meeting of the American Society of Clinical Oncology
04/06/2018
CHICAGO, June 04, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced updated clinical data from its ongoing Phase 2 study evaluating umbralisib (TGR-1202), the Company’s PI3K delta inhibitor, [...]
Stelis Biopharma and Oncobiologics to Unveil Bio2Source CDMO Offering at BIO 2018
04/06/2018
CRANBURY, N.J., June 04, 2018 (GLOBE NEWSWIRE) -- Stelis Biopharma and Oncobiologics, Inc. (NASDAQ:ONS) today announced that they will unveil a new contract development and manufacturing (“CDMO”) effort at BIO 2018 in [...]
CapsoVision Announces U.S. Distribution Partnership With PENTAX Medical
04/06/2018
The diagnostic and therapeutic endoscopy company will now sell CapsoVision capsule endoscopy solutions CapsoCam Plus® and CapsoCloud™ across the country SARATOGA, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Today Silicon [...]
Adverum Biotechnologies to Present at the 2018 Jefferies Global Healthcare Conference
04/06/2018
MENLO PARK, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq:ADVM), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced today [...]
"This is Infertility" Releases New Episodes for Pride Month 2018
04/06/2018
NEW YORK, June 04, 2018 (GLOBE NEWSWIRE) -- This is Infertility , a podcast by Progyny, announced today the release of new episodes for Pride Month 2018. One episode, each highlighting how LGBTQ couples navigate the [...]
Oncolytics Biotech® Announces Poster Presentation Demonstrating the Ability of REOLYSIN® to Promote and Predict Response to Checkpoint Inhibitors at ASCO 2018 Annual Meeting
04/06/2018
CALGARY, Alberta and SAN DIEGO, June 04, 2018 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (TSX:ONC) (NASDAQ:ONCY), currently developing REOLYSIN ® (pelareorep), an intravenously delivered immuno-oncolytic virus [...]
New Data from Phase 1 Study of Ivosidenib or Enasidenib in Combination with Azacitidine Demonstrate Robust Responses and a Well Tolerated Safety Profile in Newly Diagnosed IDHm AML Patients
04/06/2018
- Safety Profile of Combination Therapies Consistent with Single Agent IDHm Inhibitors and Azacitidine - - ORR of 78%, CR Rate of 44% and CR/CRi/CRp Rate of 65% in the Ivosidenib Arm; Molecular Clearance Observed in 7 [...]
CytomX Therapeutics Presents Preliminary Clinical Proof-of-Concept Data from Probody™ Platform and CX-072 at 2018 ASCO Annual Meeting
04/06/2018
– PD-L1 Targeting Probody CX-072 Well Tolerated and Shows Antitumor Activity as Monotherapy and in Combination with Ipilimumab – – Company to Host Conference Call and Webcast Today Monday, June 4 th at 5:00 p.m. CT / 6: [...]
Analogic Announces Results for the Third Quarter Ended April 30, 2018
04/06/2018
Special Shareholder Meeting To Approve Altaris Transaction Scheduled for June 21, 2018 PEABODY, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and [...]

Pages